Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Rainbowchildrens Med
Join Channel
Consolidated Standalone

RainbowChildrenS Med

₹1417.6 16.8 | 1.2%

Market Cap ₹14389 Cr.

Stock P/E 65.5

P/B 12

Current Price ₹1417.6

Book Value ₹ 118.4

Face Value 10

52W High ₹1649

Dividend Yield 0.21%

52W Low ₹ 807

Edit Ratio

RainbowChildrenS Med Research see more...

Stocx User

Jupiter Life Line Hospitals Ltd. Vs Rainbow Childrens Medicare Ltd

Overview Inc. Year: 1998Industry: Hospital & Healthcare Services

Rainbow Children’s Medicare Ltd is a multi-speciality obstetrics, paediatric and gynaecology hospital chain in India. The agency’s infant health offerings consist of general paediatrics, neonatalogy, surgical treatment, gastroenterology and liver sicknesses, haematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrients, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopaedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disorder, and cranio-maxillofacial surgical procedure; extensive care unit, bone marrow transplant unit, anesthesia and pain control, kidney transplant, cochlear implant services; genetics and metabolic drug treatments; and laboratory, speech and language remedy, occupational therapy, paediatric and metabolic medication, developmental and behavioural paediatrics, cerebral palsy care offerings. Its women health services comprises obstetrics and gynaecology, painless delivery and labor, high risk being pregnancy and delivery, childbirth preparation lessons, vaginal birth after cesarean, breast feeding assist, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicinal drug, menopausal treatment, new-born care, ladies's nutrients, and diabetology. The business enterprise additionally gives fertility care offerings, inclusive of fertility remedy, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor remedies, frozen embryo switch, surgical sperm retrieval, embryo donor remedies, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and three clinics in 6 towns with a total of 1500 beds. The enterprise incorporated in 1998 and is primarily based in Hyderabad, India.

Read More..

RainbowChildrenS Med Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

RainbowChildrenS Med Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 266 249 212 237 313 306 317 287 333 336
Other Income 5 6 6 6 8 8 9 8 8 9
Total Income 271 254 219 243 321 315 326 295 340 345
Total Expenditure 177 159 164 155 204 200 219 199 215 218
Operating Profit 94 95 54 88 117 115 107 96 125 127
Interest 12 12 16 14 13 14 14 15 13 14
Depreciation 21 21 22 22 22 23 23 25 27 28
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 61 62 16 52 81 78 70 56 85 85
Provision for Tax 16 17 3 13 20 20 16 14 22 22
Profit After Tax 45 45 12 39 62 58 54 41 63 63
Adjustments -0 -0 -0 -1 -0 -0 -0 -0 -0 -0
Profit After Adjustments 45 45 12 38 61 58 54 41 63 62
Adjusted Earnings Per Share 4 4.3 1.2 3.8 6 5.7 5.3 4 6.2 6.1

RainbowChildrenS Med Profit & Loss

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 321 402 543 719 650 974 1174 1273
Other Income 11 10 8 10 10 19 31 34
Total Income 332 411 551 730 660 993 1204 1306
Total Expenditure 266 332 431 519 485 666 774 851
Operating Profit 66 79 120 211 175 327 430 455
Interest 3 4 6 48 46 56 58 56
Depreciation 22 28 37 69 73 83 90 103
Exceptional Income / Expenses 0 0 0 0 0 0 0 0
Profit Before Tax 41 47 78 93 56 187 282 296
Provision for Tax 10 11 20 38 16 49 69 74
Profit After Tax 31 36 58 55 40 139 212 221
Adjustments 0 0 0 0 0 -0 -2 0
Profit After Adjustments 31 36 58 56 40 138 211 220
Adjusted Earnings Per Share 3.4 4 6.4 6.2 4.4 14.7 20.8 21.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 21% 18% 24% 0%
Operating Profit CAGR 31% 27% 40% 0%
PAT CAGR 53% 57% 43% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 76% NA% NA% NA%
ROE Average 26% 21% 18% 16%
ROCE Average 40% 35% 31% 26%

RainbowChildrenS Med Balance Sheet

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 329 362 416 405 446 603 1060
Minority's Interest 0 0 0 4 2 3 5
Borrowings 10 10 50 46 41 27 0
Other Non-Current Liabilities 4 5 7 472 468 526 541
Total Current Liabilities 56 70 86 171 122 125 144
Total Liabilities 399 448 559 1098 1078 1284 1750
Fixed Assets 174 296 344 702 772 858 931
Other Non-Current Assets 100 79 78 153 109 136 336
Total Current Assets 126 73 136 244 197 290 484
Total Assets 399 448 559 1098 1078 1284 1750

RainbowChildrenS Med Cash Flow

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 4 5 3 5 7 6 10
Cash Flow from Operating Activities 36 48 90 170 143 224 327
Cash Flow from Investing Activities -33 -42 -117 -117 -83 -175 -465
Cash Flow from Financing Activities -1 -7 28 -52 -61 -44 143
Net Cash Inflow / Outflow 1 -2 2 2 -1 4 5
Closing Cash & Cash Equivalent 5 3 5 7 6 10 15

RainbowChildrenS Med Ratios

# Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 3.43 3.96 6.4 6.18 4.44 14.7 20.77
CEPS(Rs) 5.9 7.14 10.52 13.84 12.53 23.6 29.82
DPS(Rs) 2.5 1 1 2 0 2 3
Book NAV/Share(Rs) 35.24 38.93 44.88 43.77 48.32 62.93 104.42
Core EBITDA Margin(%) 17.1 17.3 20.61 27.9 25.4 31.61 34.05
EBIT Margin(%) 13.74 12.7 15.35 19.69 15.7 25.01 28.99
Pre Tax Margin(%) 12.84 11.64 14.3 12.98 8.57 19.24 24.01
PAT Margin (%) 9.76 9.03 10.67 7.69 6.09 14.24 18.1
Cash Profit Margin (%) 16.57 16.02 17.47 17.34 17.37 22.79 25.79
ROA(%) 7.86 8.57 11.51 6.68 3.64 11.74 14
ROE(%) 9.87 10.85 15.34 13.85 9.54 27 25.72
ROCE(%) 12.83 14.2 19.81 30.56 21.42 42.92 39.96
Receivable days 15.54 13.2 14.78 18.4 24.69 15.81 15.36
Inventory Days 7.65 5.78 4.36 5.83 7.32 4.67 5.22
Payable days 142.04 134.98 134.76 161.38 197.76 110.68 171.64
PER(x) 0 0 0 0 0 0 35.16
Price/Book(x) 0 0 0 0 0 0 6.99
Dividend Yield(%) 0 0 0 0 0 0 0.41
EV/Net Sales(x) -0.16 0.08 0.06 0.02 0.01 -0.04 6.28
EV/Core EBITDA(x) -0.8 0.41 0.25 0.06 0.03 -0.12 17.11
Net Sales Growth(%) 0 25.07 35.08 32.54 -9.64 49.8 20.52
EBIT Growth(%) 0 15.65 63.19 69.99 -27.93 138.58 39.69
PAT Growth(%) 0 15.74 59.67 -4.47 -28.5 250.47 53.15
EPS Growth(%) 0 15.65 61.61 -3.41 -28.19 231.04 41.3
Debt/Equity(x) 0.05 0.04 0.12 0.14 0.1 0.07 0
Current Ratio(x) 2.26 1.03 1.58 1.42 1.61 2.32 3.35
Quick Ratio(x) 2.14 0.95 1.5 1.33 1.53 2.2 3.22
Interest Cover(x) 15.25 11.96 14.64 2.93 2.2 4.34 5.83
Total Debt/Mcap(x) 0 0 0 0 0 0 0

RainbowChildrenS Med Shareholding Pattern

# Mar 2018 Mar 2019 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 60.54 60.54 49.83 49.83 49.83 49.83 49.83 49.83 49.83 49.83
FII 0 0 8.52 10.93 20.81 19.82 20.19 21.63 22.32 24.04
DII 8.87 8.87 23.89 15.22 13.9 15.38 15.35 15.4 15.62 14.76
Public 30.59 30.59 17.76 24.03 15.46 14.97 14.63 13.14 12.23 11.37
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 42% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 21%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 49.83%.
  • Debtor days have increased from 110.68 to 171.64days.
  • Stock is trading at 12 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

RainbowChildrenS Med News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!